Digital Companion Diagnostics Market Outlook 2026: Trends & Insights According to a newly published market research report by 24LifeSciences, global digital companion diagnostics market was valued at USD 5.2 billion in 2025 and is projected to reach USD 11.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 10.5% during the forecast period. Digital companion diagnostics are specialized in vitro diagnostic tests that provide essential information for the safe and effective use of a corresponding therapeutic product. These advanced tools analyze specific biomarkers such as genetic mutations or protein expressions to identify patients who are most likely to benefit from a particular drug or who may be at increased risk of serious side effects. By enabling personalized treatment decisions, these diagnostics are fundamentally transforming patient care, particularly in complex therapeutic areas like oncology, where they guide targeted therapies and immunotherapies with unprecedented precision. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9120/digital-companion-diagnostics-market

Companion Diagnostics Market Outlook 2025: Global Industry Insights, Trends, and Growth Opportunities As per Straits Research the global companion diagnostics market size was valued at USD 5.87 billion in 2024 and is projected to reach USD 17.34 billion by 2033, growing at a CAGR of 12.8% % during the forecast period (2025-2033). Get more insights @ https://straitsresearch.com/report/companion-diagnostics-market